The sympathetic skin response (SSR) at the foot to a deep inspiration was measured in 68 randomly selected diabetic patients and 46 age matched normal subjects and compared with other quantitative measures of neurological and sudomotor function. SSR was obtained in all but three diabetic patients. The upper limit of normal for the onset latency was 2202 ms and the lower limit for the amplitude of the first wave 92 uV. Ten diabetic patients had measurable but prolonged latencies, and 11 had measurable but low amplitudes. There were no significant associations between latency, height, and age, but in insulin dependent patients there was a significant diminution of response amplitude with increasing duration of diabetes. Latency was weakly associated with Marstock thermal thresholds, respiratory RR variation, and common peroneal nerve conduction velocity. SSR amplitude was associated with the density of pilocarpine activatable sweatspots in the same region of the foot. Patients with abnormal latencies were significantly older and had reduced thermal sensation than those with normal latencies. Median coefficients of variation for repeat testing in diabetic patients were 90/o for latency and 13% for amplitude. The test is objective and reproducible, but latency measurements reflect conduction in a long multineuronal pathway and are not purely a measure of peripheral C fibre function; amplitude measurements reflect the density of spontaneously activable sweat glands and are therefore a valid measure of peripheral sympathetic activity, though they depend more on temperature than do latencies (mean change over the range 32-34°C; 8-5%°C for amplitude, -2-5%l/°C for latency). 
The sympathetic skin response (SSR) at the foot to a deep inspiration was measured in 68 randomly selected diabetic patients and 46 age matched normal subjects and compared with other quantitative measures of neurological and sudomotor function. SSR was obtained in all but three diabetic patients. The upper limit of normal for the onset latency was 2202 ms and the lower limit for the amplitude of the first wave 92 uV. Ten diabetic patients had measurable but prolonged latencies, and 11 had measurable but low amplitudes. There were no significant associations between latency, height, and age, but in insulin dependent patients there was a significant diminution of response amplitude with increasing duration of diabetes. Latency was weakly associated with Marstock thermal thresholds, respiratory RR variation, and common peroneal nerve conduction velocity. SSR amplitude was associated with the density of pilocarpine activatable sweatspots in the same region of the foot. Patients with abnormal latencies were significantly older and had reduced thermal sensation than those with normal latencies. Median coefficients of variation for repeat testing in diabetic patients were 90/o for latency and 13% for amplitude. The test is objective and reproducible, but latency measurements reflect conduction in a long multineuronal pathway and are not purely a measure of peripheral C fibre function; amplitude measurements reflect the density of spontaneously activable sweat glands and are therefore a valid measure of peripheral sympathetic activity, though they depend more on temperature than do latencies (mean change over the range 32-34°C; 8-5%°C for amplitude, -2-5%l/°C for latency). The quantitation of distal sympathetic function is of considerable interest in diabetic neuropathy, where peripheral small fibre dysfunction is an important facilitatory factor in the generation of diabetic foot ulceration' and of Charcot joints.2 Spinal sympathetic outflow is directed to muscle as muscle sympathetic activity, causing vasodilatation in muscle capillaries, and to skin (skin sympathetic activity), regulating skin blood flow and sweat gland function. Microneurography is able to detect these activities independently,3 but it is a difficult technique and cannot be used to study large numbers of subjects. Non Glycated haemoglobin (%) (n = 52) 11-3 (2-8, 6-5-16-5) Random plasma glucose (mmol/l) (n = 42) 10-0 (4-4, 3-9-19-0) and venous blood was taken for glucose and glycated haemoglobin (affinity chromatographic method, reference range <8.0%) at the end of testing.
MEASUREMENT OF SSR
We used a method modified from that of Shahani et al. 5 Tests were performed on the right leg. All electrodes, apart from the earth, which was a plate EMG electrode attached to the lateral side of the lower leg, were standard Ag-AgCl disposable ECG monitoring electrodes (3M Corporation, Minnesota) and recordings were made on a Nicolet Viking electromyograph (Nicolet Medical Instruments, Coventry). We used a deep inspiration as the stimulus, and after a demonstration the subject was allowed to practice this unfamiliar manoeuvre. Intercostal EMG was recorded with two electrodes attached to the right lower lateral chest wall (over 7th-9th intercostal spaces), and SSR with electrodes on the midtarsal portion of the dorsum of the foot and on the sole of the foot immediately opposite the dorsal electrode. Recordings were made simultaneously on two channels, one recording intercostal muscle activity, the other the SSR. The filter settings used were 0 5 Hz (high pass) and 100 Hz (low pass). These were chosen as the lowest frequencies available on the Nicolet Viking, though it is likely that the recording would be further improved if an even lower filter frequency were available. Twelve responses were recorded. To allow for the habituation of the response, stimuli were separated by at least one minute. Tracings were stored on disc for later analysis. Digital averaging was not available on theViking at the slow sweep speeds used, and each response was analysed individually using electronic cursor placements. The mean of the 12 responses was calculated for the following measurements: (1) onset latency (ms): the time between onset of intecostal activity and first (usually negative) deflection; (2) amplitude (uV): the baselinepeak measurement of the first and second deflections; in some cases third (negative) and fourth (positive) deflections were seen, but not measured. In 10% of diabetic patients the responses were "inverted" (that is, positive followed by negative wave); in these cases absolute measurements from baseline were used; (3) Peak latency (ms): the time between onset of first deflection and the first and second peaks. Figure 1 shows the conventions used for measuring latencies and amplitudes on a typical tracing. Pilocarpine-activated sweatspot density (No/ cm2) was measured at the dorsolateral aspect of the foot, using imprints on bromophenol blue indicator papers after pilocarpine iontophoresis (1% in 4% agar gel at 1*5 mA for five minutes). Prints were then analysed by computerised image analysis (Quantimet 970, Leica Instruments, Cambridge). Sweat output (mg) over a 1I7 cm2 area of the dorsolateral aspect of the foot was measured for 12 min after five minutes of acetylcholine iontrophoresis (1% in gel at 1-5 mA) using a directly calibrated computerised ventilated capsule sudorometer. shows that this patient appreciably affected the postural change in blood pressure. Large fibre tests-There were no significant ations with age, height, duration of diabetes, associations with vibration perception threshic control, and sex olds, but there were weak associations with normal subjects, there was no change in electrophysiological measurements (common latency with age (r = 0 19, p = 0 13) peroneal motor conduction velocity and SSR he patient discussed above was excluded. latency: r = -044, p = 0-01; shortest f itudes of peaks 1 and 2 decreased with latency and SSR latency: r = 0 40, p = 0 05; eak 1: r = -0-47, p < 0001; peak 2: sural action potential amplitude (SSAP) and 0-23, p = 006). In the whole group, no SSR latency: r = -037, p = 0-06; SSAP and rements were related to known duration SSR amplitude: r = 0-41, p = 0-03). betes, but onset latency increased with Reproducibility-Median coefficient of variaon of diabetes in insulin dependent tion for onset latency was 16% (2-22%) in Its (r = 0-29, n = 38, p = 0-07) and the normal subjects and 9% (4-14%) in diabetic ude of peak 1 decreased significantly patients. Corresponding results for peak 1 -0-42, n = 38, p < 0001) (fig 4) . amplitude were 30% (13-44%) in normal the tall elderly neuropathic patient was subjects and 13% (3-69%) in diabetic led, there was no significant association patients. en onset latency and height (r = 0 14, '-29). Blood glucose and glycated haemo-CHARACTERISTICS OF PATEINTS WITH ABNORMAL X were not associated with any of the RESPONSES rements. Latencies were significantly The 13 patients with prolonged or unmeasurin men than in women (1927 (356) ms able latencies were significantly older than Table 2 Comparison of diabetic patients with absent or prolonged (> 2202 ms) mean onset latency (n = 13) and those with normal latencies (n = 55). Type 2 (Non-insulin dependent) 7 16 Height ( function. The logarithmic distribution of SSR amplitudes in normal subjects means that after appropriate transformation the lower limit of the reference range (2 SD below the mean) does not include an absent response. When present, latency measurements were longer and response amplitudes smaller in diabetic subjects than in normal subjects of a comparable age. Test-retest reproducibility was similar to that of other neurological measurements in diabetic neuropathy, though appreciably higher for SSR amplitude than for the latency, and larger in diabetic than normal subjects. It is of interest that a microneurographic study found that, although mean integrated neural activity varied with the type of stimulus used, amplitudes were relatively constant, the most important factor being that the stimuli should be delivered randomly in time."7
The increased detection rate in this study compared with other reports may be due to the population studied, in particular its relatively young mean age and short duration of diabetes. In most previous reports, SSR has been studied in patients with symptomatic neuropathy, instrumental evidence of peripheral neuropathy, or both; consequently the prevalence of undetectable responses has been reported as 40-83%. One recent study detected the response in the arm in all but 9% of subjects but did not study the leg, where peripheral neuropathy is more severe.8 In addition to patient selection, however, three technical factors may have influenced our results. Firstly, we used the lowest available cutoff frequency for the high pass filter; the higher settings used in previous studies would tend to decrease the response amplitude. Secondly, we used a deep inspiration rather than electrical nerve trunk stimulation; Shahani et al found that using the inspiration yielded responses of larger amplitude than direct electrical stimulation. longed onset latency, all but three had abnormal Marstock warm thresholds, though five had normal respiratory RR interval variation. However, seven had three abnormal cardiovascular vagal autonomic tests, though of these only one had symptomatic autonomic neuropathy. The rate of abnormality in the whole group was lower than that for thermal threshold testing (31% for warm thresholds). Several factors may be responsible for this difference: registration of the SSR requires a coordinated sweat gland response, and the efferent pathway to a large group of glands probably has to be damaged substantially in order to delay the onset of the response. An abnormal psychophysical threshold, on the other hand, may occur when there are minimal abnormalities of temporal or spatial summation of impulses.
Shahani et al suggested that the SSR reflects abnormal small fibre function in predominantly axonal neuropathies, rather than clinically disorderd autonomic function.5 This is to be expected, since most symptoms of autonomic dysfunction in diabetes are due to abnormalities of proximal parasympathetic rather than of distal sympathetic function, symptoms of which (postural hypotension, gross abnormalities of sweating) are late features of diabetic neuropathy. In fact, the association between SSR, thermal and pain sensation, and the other sweat tests (apart from the association between peak 1 amplitude and pilocarpine activatable sweatspot density) was poor, reflecting the fact that local sweat tests assess function of postganglionic sympathetic nerve terminals and sweat gland receptors, and it is unlikely that their function changes together with that of the whole sympathetic pathway. There was also a poor association with the largely parasympathetic cardiac autonomic function tests, though the association with the most reproducible of the tests, respiratory RR variation, just reached statistical significance. The lack of association with postural changes in blood pressure is unexpected and at variance with the report of Watahiki et al9 probably as result of the variability and lack of standardisation of measurements. 
